MRK
Published on 07/09/2025 at 06:31, updated on 07/09/2025 at 06:32
--Merck is nearing a roughly $10 billion deal to buy lung disease-focused drugmaker Verona Pharma, the Financial Times reports, citing people familiar with the matter.
--Merck would pay $107 per American depository share for Verona under the proposed deal, a 23% premium to Tuesday's closing price of $86.86, the FT reports.
--A deal could be announced as soon as Wednesday, the FT reports, adding that Merck declined to comment, while Verona didn't immediately respond to a request for comment.
Full story: https://www.ft.com/content/bf1c2253-15b3-426a-975d-15ddca1d84a5
Write to Colin Kellaher at [email protected]
(END) Dow Jones Newswires
07-09-25 0630ET